Uroplasty appoints CFO

Uroplasty (UPI -6%), a provider of devices for treating voiding dysfunctions, names Brett Reynolds as CFO.

Reynolds most recently held the same position at Synovis Life Technologies, which was sold to Baxter International in February 2012 for $325M. (PR)

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs